Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.AuthorsFalchook, Gerald S.; Peeters, Marc; Rottey, Sylvie; Dirix, Luc Y.; Obermannova, Radka; Cohen, Jonathan E.; Perets, Ruth; Frommer, Ronnie Shapira; Bauer, Todd M.; Wang, Judy S.; Carvajal, Richard D.; Sabari, Joshua; Chapman, Sonya; Zhang, Wei; Calderon, Boris; Peterson, Daniel A.PublicationInvestigational New Drugs, 2021, Vol 39, Issue 5, p1284ISSN0167-6997Publication typeArticleDOI10.1007/s10637-021-01088-4